Therapeutic Potential of PI3K/AKT/mTOR Pathway in Gastrointestinal Stromal Tumors: Rationale and Progress.

Duan, Yi; Haybaeck, Johannes; Yang, Zhihui

Duan, Yi; Haybaeck, Johannes; Yang, Zhihui.

Afiliação

Duan Y; Department of Pathology, the Affiliated Hospital of Southwest Medical University, Luzhou 646000, China.
Haybaeck J; Department of Pathology, Neuropathology and Molecular Pathology, Medical University of Innsbruck, 6020 Innsbruck, Austria.
Yang Z; Diagnostic & Research Center for Molecular BioMedicine, Institute of Pathology, Medical University of Graz, 8010 Graz, Austria.

Cancers (Basel) ; 12(10)2020 Oct 14.

Article em En | MEDLINE | ID: mdl-33066449

Palavras-chave

PI3K/AKT/mTOR; eIFs; gastrointestinal stromal tumors; inhibitor

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China País de publicação: Suíça

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google